Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Organovo Holdings Inc.
Fiscal year is April-March. All values USD millions. 2010 2011 2013 2014 5-year trend
Sales/Revenue - 603,412 968,513 860,000 379,000
Cost of Goods Sold (COGS) incl. D&A - 58,669 133,607 320,000 387,000
COGS excluding D&A - 0 65,507 0 0
Depreciation & Amortization Expense - 58,669 68,100 320,000 387,000
Depreciation - 57,169 62,900 312,000 378,500
Amortization of Intangibles - 1,500 5,200 8,000 8,500
Gross Income - 544,743 834,906 540,000 (8,000)
2010 2011 2013 2014 5-year trend
SG&A Expense - 1.72M 3.12M 14.24M 20.64M
Research & Development - 1.2M 1.42M 5.79M 7.97M
Other SG&A - 519,245 1.71M 8.45M 12.67M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 12.63M 5.12M
EBIT after Unusual Expense - 0 0 (12.63M) (5.12M)
Non Operating Income/Expense - 316 (26,454) 0 (84,000)
Non-Operating Interest Income - 81 64 16,000 18,000
Equity in Affiliates (Pretax) - 0 0 0 -
Interest Expense - 160,873 2.07M 260,000 13,000
Gross Interest Expense - 160,873 2.07M 260,000 13,000
Interest Capitalized - 0 0 0 0
Pretax Income - (1.34M) (4.38M) (26.58M) (25.85M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 -
Income Tax - Current Foreign - 0 0 0 -
Income Tax - Deferred Domestic - 0 0 0 -
Income Tax - Deferred Foreign - 0 0 0 -
Income Tax Credits - 0 0 0 -
Equity in Affiliates - 0 0 0 -
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (1.34M) (4.38M) (26.58M) (25.85M)
Minority Interest Expense - 0 0 0 0
Net Income - (1.34M) (4.38M) (26.58M) (25.85M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (1.34M) (4.38M) (26.58M) (25.85M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1.34M) (4.38M) (26.58M) (25.85M)
EPS (Basic) - (0.01) (0.02) (0.43) (0.35)
Basic Shares Outstanding - 155.65M 237.55M 61.75M 73.14M
EPS (Diluted) - (0.01) (0.02) (0.43) (0.35)
Diluted Shares Outstanding - 155.65M 237.55M 61.75M 73.14M
EBITDA - (1.12M) (2.22M) (13.38M) (20.26M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.